propranolol has been researched along with Pituitary Neoplasms in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The hypercalcemia was not reversed by dexamethasone or propranolol treatment, but was ameliorated by starvation." | 3.67 | Hypercalcemia in rats bearing growth hormone- and prolactin-secreting transplantable pituitary tumors. ( Brickman, AS; Carlson, HE; Deftos, LJ; Forte, LR; Horst, RL; Lamberts, SW, 1985) |
| "There was no indication that pituitary adenomas were etiologic agents for the hyperprolactinemia." | 1.26 | Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea. ( Bhatnagar, AS; Board, JA; Fierro, RJ; Wasserman, AJ, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, K | 1 |
| Reisine, T | 1 |
| Kebabian, JW | 1 |
| Reisine, TD | 1 |
| Heisler, S | 1 |
| Hook, VY | 1 |
| Axelrod, J | 1 |
| Matsushita, F | 1 |
| Arita, E | 1 |
| Fujisawa, M | 1 |
| Fuke, N | 1 |
| Wakushima, Y | 1 |
| Suwa, K | 1 |
| Inada, Y | 1 |
| Sakai, T | 1 |
| Thaw, C | 1 |
| Wittlin, SD | 1 |
| Gershengorn, MC | 1 |
| Sarría, A | 1 |
| Garagorri, J | 1 |
| Ferrández, A | 1 |
| Calatayud, V | 1 |
| Garin, P | 1 |
| Sanz, J | 1 |
| Bueno, M | 1 |
| Villeneuve, JP | 1 |
| Gerber, JG | 1 |
| Branch, RA | 1 |
| Shand, DG | 1 |
| Wilson, JT | 1 |
| Board, JA | 1 |
| Fierro, RJ | 1 |
| Wasserman, AJ | 1 |
| Bhatnagar, AS | 1 |
| Henneberry, RC | 1 |
| Jahangeer, S | 1 |
| Lysko, PG | 1 |
| Ho, KY | 1 |
| Evans, WS | 1 |
| Thorner, MO | 1 |
| Carlson, HE | 1 |
| Lamberts, SW | 1 |
| Brickman, AS | 1 |
| Deftos, LJ | 1 |
| Horst, RL | 1 |
| Forte, LR | 1 |
| Malarkey, WB | 1 |
| Daughaday, WH | 1 |
1 review available for propranolol and Pituitary Neoplasms
| Article | Year |
|---|---|
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Ho | 1985 |
10 other studies available for propranolol and Pituitary Neoplasms
| Article | Year |
|---|---|
Adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase activity in rodent pituitary tissue: possible role in cAMP-dependent hormone secretion.
Topics: Adrenocorticotropic Hormone; Animals; Calcimycin; Cell Line; Cholera Toxin; Colforsin; Cyclic AMP; D | 1984 |
Activation of beta 2-adrenergic receptors on mouse anterior pituitary tumor cells increases cyclic adenosine 3':5'-monophosphate synthesis and adrenocorticotropin release.
Topics: Adrenocorticotropic Hormone; Animals; Cell Line; Cell Membrane; Cyclic AMP; Dihydroalprenolol; Epine | 1983 |
[Facial pain and headache after the surgical removal of a prolactin producing pituitary microadenoma].
Topics: Acupuncture Therapy; Adenoma; Adult; Face; Female; Headache; Humans; Menstruation; Pain, Postoperati | 1984 |
Tetracaine, propranolol and trifluoperazine inhibit thyrotropin releasing hormone-induced prolactin secretion from GH3 cells by displacing membrane calcium: further evidence that TRH acts to mobilize cellular calcium.
Topics: Animals; Calcium; Cell Line; Cell Membrane; Pituitary Neoplasms; Prolactin; Propranolol; Rats; Tetra | 1982 |
Follow-up hormonal controls on a HGH secreting pituitary adenoma. Pre- and postoperative study.
Topics: Adenoma; Child; Follow-Up Studies; Glucagon; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prop | 1980 |
Drug metabolism in rats bearing a pituitary mammotropic tumor.
Topics: Aminopyrine; Animals; Antipyrine; Cardiac Output; Half-Life; Liver; Male; Mammary Glands, Animal; Ne | 1979 |
Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea.
Topics: Adenoma; Adult; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; Phentolamine; Pituitary | 1977 |
Transport of beta-adrenergic antagonists in the absence of beta-adrenergic receptors in rat pituitary tumor cells.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Biological Transport; Cell Line; Colfors | 1986 |
Hypercalcemia in rats bearing growth hormone- and prolactin-secreting transplantable pituitary tumors.
Topics: Animals; Creatinine; Dexamethasone; Female; Growth Hormone; Hypercalcemia; Magnesium; Neoplasm Trans | 1985 |
The influence of levodopa and adrenergic blockade on growth hormone and prolactin secretion in the MStTW15 tumor bearing rat.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Depression, Chemical; Dihydroxyp | 1972 |